Severe skin infections
- PMID: 37641501
- DOI: 10.1097/MCC.0000000000001069
Severe skin infections
Abstract
Purpose of review: The incidence of necrotizing soft-tissue infections (NSTI) has increased during recent decades. These infections are still associated with high morbidity and mortality, underlining a need for continued education of the medical community. This review will focus on practical approaches to management of NSTI focusing on antibiotic therapies and optimizing the management of group A streptococcus (GAS)-associated NSTIs.
Recent findings: Antibiotic therapy for NSTI patients faces several challenges as the rapid progression of NSTIs mandates broad-spectrum agents with bactericidal action. Current recommendations support using clindamycin in combination with penicillin in case of GAS-documented NSTIs. Linezolide could be an alternative in case of clindamycin resistance.
Summary: Reducing the time to diagnosis and first surgical debridement, initiating early broad-spectrum antibiotics and early referral to specialized centres are the key modifiable factors that may impact the prognosis of NSTIs. Causative organisms vary widely according to the topography of the infection, underlying conditions, and geographic location. Approximately one third of NSTIs are monomicrobial, involving mainly GAS or Staphylococcus aureus . Data for antibiotic treatment specifically for necrotizing soft-tissue infections are scarce, with guidelines mainly based on expert consensus.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
-
Impact of Empiric Linezolid for Necrotizing Soft Tissue Infections on Duration of Methicillin-Resistant Staphylococcus aureus-Active Therapy.Surg Infect (Larchmt). 2022 Apr;23(3):313-317. doi: 10.1089/sur.2021.329. Epub 2022 Feb 8. Surg Infect (Larchmt). 2022. PMID: 35133888
-
Association between adjunct clindamycin and in-hospital mortality in patients with necrotizing soft tissue infection due to group A Streptococcus: a nationwide cohort study.Eur J Clin Microbiol Infect Dis. 2022 Feb;41(2):263-270. doi: 10.1007/s10096-021-04376-2. Epub 2021 Nov 9. Eur J Clin Microbiol Infect Dis. 2022. PMID: 34755257
-
Outcomes of β-Hemolytic Streptococcal Necrotizing Skin and Soft-tissue Infections and the Impact of Clindamycin Resistance.Clin Infect Dis. 2021 Dec 6;73(11):e4592-e4598. doi: 10.1093/cid/ciaa976. Clin Infect Dis. 2021. PMID: 33151283 Free PMC article.
-
Antibiotics in Necrotizing Soft Tissue Infections.Antibiotics (Basel). 2021 Sep 13;10(9):1104. doi: 10.3390/antibiotics10091104. Antibiotics (Basel). 2021. PMID: 34572686 Free PMC article. Review.
-
Regional Variations in Microbiology and Outcomes of Necrotizing Soft Tissue Infections: A Systematic Review and Meta-Analysis.Surg Infect (Larchmt). 2022 Sep;23(7):634-644. doi: 10.1089/sur.2022.142. Epub 2022 Jul 29. Surg Infect (Larchmt). 2022. PMID: 35904966
Cited by
-
Treating necrotizing skin and soft-tissue infections.Intensive Care Med. 2024 Aug;50(8):1342-1345. doi: 10.1007/s00134-024-07466-9. Epub 2024 May 16. Intensive Care Med. 2024. PMID: 38753269 No abstract available.
References
-
- Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005; 41:1373–1406.
-
- Goh T, Goh LG, Ang CH, Wong CH. Early diagnosis of necrotizing fasciitis. Br J Surg 2014; 101:e119–e125.
-
- Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med 2017; 377:2253–2265.
-
- Arif N, Yousfi S, Vinnard C. Deaths from necrotizing fasciitis in the United States, 2003–2013. Epidemiol Infect 2016; 144:1338–1344.
-
- Gawaziuk JP, Strazar R, Cristall N, Logsetty S. Factors predicting health-related quality of life following necrotizing fasciitis. J Plast Reconstr Aesthet Surg 2018; 71:857–862.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials